Skip Navigation


NDT Advance Access originally published online on September 8, 2006
Nephrology Dialysis Transplantation 2007 22(1):257-258; doi:10.1093/ndt/gfl482
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/1/257    most recent
gfl482v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Santos-Araújo, C.
Right arrow Articles by Pestana, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santos-Araújo, C.
Right arrow Articles by Pestana, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Combined use of plasmapheresis and antidigoxin antibodies in a patient with severe digoxin intoxication and acute renal failure

Carla Santos-Araújo1, Martins Campos2, Cristina Gavina2, F. Rocha-Gonçalves2 and Manuel Pestana1

1Nephrology Department and 2Cardiology Department, Faculty of Medicine, Hospital S. João, Porto, Portugal

Correspondence and offprint requests to: C. Santos-Araújo, Nephrology Department, Faculty of Medicine, Hospital S. João, Porto, Portugal. Email: csaraujo@tvtel.pt

Keywords: digitalis intoxication; renal failure; plasmapheresis

The first 10% of the full text of this article appears below.

Digitalis intoxication is a common and potentially life-threatening situation [1]. In this condition, the administration of digoxin-specific antibodies (Fab) have proven to be effective in controlling serious complications [2]. However, in patients with severe renal impairment, the clearance of Fab–digoxin complexes is . . . [Full Text of this Article]



   Case
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?